Search research articles
Contact Us
Filters
Showing results (81-90 of 97) with videos related to
Page
of 10
Sort By:
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Functional interrogation uncovers a critical role for a high-plasticity cell state in lung adenocarcinoma
Jason E Chan, Chun-Hao Pan, Jonathan Rub, et al.
Scientific Reports
|
January 22, 2025
Detection and genomic characterisation of foot-and-mouth disease virus serotypes circulating in Cameroon using environmental sampling
Claire Colenutt, Andrew Shaw, Seraphine Nkie Esemu, et al.
Journal of Psychopathology and Clinical Science
|
April 6, 2023
Neurobiological and genetic correlates of the dissociative subtype of posttraumatic stress disorder
Erika J Wolf, Sage E Hawn, Danielle R Sullivan, et al.
BMC Psychiatry
|
December 7, 2019
Association of Borderline Intellectual Functioning and Adverse Childhood Experience with adult psychiatric morbidity. Findings from a British birth cohort
Angela Hassiotis, Emma Brown, James Harris, et al.
Access Microbiology
|
October 21, 2024
Environmental sampling for the detection of capripox viruses and peste des petits ruminants virus in households and livestock markets in Plateau State, Nigeria
Emma Brown, David Ehizibolo, Banenat B Dogonyaro, et al.
European Urology Oncology
|
November 5, 2025
Prostate-specific Antigen and Objective Response Analyses in PROpel: Olaparib Plus Abiraterone Versus Placebo Plus Abiraterone as First-line Therapy for Metastatic Castration-resistant Prostate Cancer
Fred Saad, Andrew J Armstrong, Mototsugu Oya, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
April 21, 2023
Transrectal Absorber Guide Raster-Scanning Optoacoustic Mesoscopy for Label-Free In Vivo Assessment of Colitis
Adrian Buehler, Emma Brown, Lars-Philip Paulus, et al.
Elife
|
August 23, 2024
Inhibitors of the small membrane (M) protein viroporin prevent Zika virus infection
Emma Brown, Gemma Swinscoe, Daniella A Lefteri, et al.
European Urology Oncology
|
October 9, 2024
Efficacy and Safety of Olaparib Plus Abiraterone Versus Placebo Plus Abiraterone in the First-line Treatment of Patients with Asymptomatic/Mildly Symptomatic and Symptomatic Metastatic Castration-resistant Prostate Cancer: Analyses from the Phase 3 PROpel Trial
Noel W Clarke, Andrew J Armstrong, Mototsugu Oya, et al.
The Lancet. Oncology
|
September 15, 2023
Olaparib plus abiraterone versus placebo plus abiraterone in metastatic castration-resistant prostate cancer (PROpel): final prespecified overall survival results of a randomised, double-blind, phase 3 trial
Fred Saad, Noel W Clarke, Mototsugu Oya, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 97) with videos related to
Sort By:
Page
of 10
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Functional interrogation uncovers a critical role for a high-plasticity cell state in lung adenocarcinoma
Jason E Chan, Chun-Hao Pan, Jonathan Rub, et al.
Scientific Reports
|
January 22, 2025
Detection and genomic characterisation of foot-and-mouth disease virus serotypes circulating in Cameroon using environmental sampling
Claire Colenutt, Andrew Shaw, Seraphine Nkie Esemu, et al.
Journal of Psychopathology and Clinical Science
|
April 6, 2023
Neurobiological and genetic correlates of the dissociative subtype of posttraumatic stress disorder
Erika J Wolf, Sage E Hawn, Danielle R Sullivan, et al.
BMC Psychiatry
|
December 7, 2019
Association of Borderline Intellectual Functioning and Adverse Childhood Experience with adult psychiatric morbidity. Findings from a British birth cohort
Angela Hassiotis, Emma Brown, James Harris, et al.
Access Microbiology
|
October 21, 2024
Environmental sampling for the detection of capripox viruses and peste des petits ruminants virus in households and livestock markets in Plateau State, Nigeria
Emma Brown, David Ehizibolo, Banenat B Dogonyaro, et al.
European Urology Oncology
|
November 5, 2025
Prostate-specific Antigen and Objective Response Analyses in PROpel: Olaparib Plus Abiraterone Versus Placebo Plus Abiraterone as First-line Therapy for Metastatic Castration-resistant Prostate Cancer
Fred Saad, Andrew J Armstrong, Mototsugu Oya, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
April 21, 2023
Transrectal Absorber Guide Raster-Scanning Optoacoustic Mesoscopy for Label-Free In Vivo Assessment of Colitis
Adrian Buehler, Emma Brown, Lars-Philip Paulus, et al.
Elife
|
August 23, 2024
Inhibitors of the small membrane (M) protein viroporin prevent Zika virus infection
Emma Brown, Gemma Swinscoe, Daniella A Lefteri, et al.
European Urology Oncology
|
October 9, 2024
Efficacy and Safety of Olaparib Plus Abiraterone Versus Placebo Plus Abiraterone in the First-line Treatment of Patients with Asymptomatic/Mildly Symptomatic and Symptomatic Metastatic Castration-resistant Prostate Cancer: Analyses from the Phase 3 PROpel Trial
Noel W Clarke, Andrew J Armstrong, Mototsugu Oya, et al.
The Lancet. Oncology
|
September 15, 2023
Olaparib plus abiraterone versus placebo plus abiraterone in metastatic castration-resistant prostate cancer (PROpel): final prespecified overall survival results of a randomised, double-blind, phase 3 trial
Fred Saad, Noel W Clarke, Mototsugu Oya, et al.
Page
of 10